申请人:Haydon David John
公开号:US20120004221A1
公开(公告)日:2012-01-05
Compounds of formula (I) have antibacterial activity:
wherein: m is 0 or 1; Q is hydrogen or cyclopropyl; Alk is an optionally substituted, divalent C
1
-C
6
alkylene, alkenylene or alkynylene radical which may contain an ether (—O—), thioether (—S—) or amino (—NR)— link, wherein R is hydrogen, —CN or C
1
-C
3
alkyl; X is —C(═O)NR
6
—, —S(O)NR
6
—, —C(═O)O— or —S(═O)O— wherein R
6
is hydrogen, optionally substituted C
1
-C
6
alkyl, C
2
-C
6
alkenyl, C
2
-C
6
alkynyl, -Cyc, or —(C
1
-C
3
alkyl)-Cyc wherein Cyc is optionally substituted monocyclic carbocyclic or heterocyclic having 3-7 ring atoms; Z is N; R
2
and R
3
are as defined in the description.
化合物的化学式(I)具有抗菌活性:其中:m为0或1;Q为氢或环丙基;Alk为可选取代的二价C1-C6烷基,烯基或炔基基团,可能包含醚(-O-),硫醚(-S-)或氨基(-NR)链接,其中R为氢,-CN或C1-C3烷基;X为-C(═O)NR6-,-S(O)NR6-,-C(═O)O-或-S(═O)O-,其中R6为氢,可选取代的C1-C6烷基,C2-C6烯基,C2-C6炔基,-Cyc或-(C1-C3烷基)-Cyc,其中Cyc为可选取代的具有3-7环原子的单环碳环或杂环;Z为N;R2和R3如描述中所定义。